文献速递前列腺增生与排尿功能障碍

良性前列腺梗阻微创术后5年再干预率比较

Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup.
PubMed 文献 · J Urol · 2020-10-26

基于德国医保数据纳入43,041例接受经尿道电切、光选择性汽化、激光剜除或开放简单前列腺切除术的男性患者,随访5年。光选择性汽化再干预风险显著高于经尿道电切,开放简单前列腺切除术风险更低,激光剜除与电切无显著差异。

要点

  • 光选择性汽化5年再干预风险显著高于经尿道电切(HR 1.31)。
  • 开放简单前列腺切除术再干预风险显著低于经尿道电切(HR 0.43)。
  • 激光剜除与经尿道电切再干预风险无显著差异(HR 0.84,p=0.2)。

核心结论

  • 经尿道电切与激光剜除5年再干预率无显著差异,光选择性汽化再干预率显著更高,开放简单前列腺切除术长期疗效仍优于经尿道电切。

研究设计与样本

  • 基于德国地方医保基金匿名理赔与核心数据,纳入2011至2013年间接受经尿道电切(34,526例)、光选择性汽化(3,050例)、激光剜除(1,814例)或开放简单前列腺切除术(3,651例)的43,041例男性患者,随访5年。

主要发现

  • 5年内共实施5,050例首次再干预,无再干预生存率为87.5%(95% CI 87.2%-87.8%)。
  • 光选择性汽化再干预风险高于经尿道电切(HR 1.31,95% CI 1.17-1.46,p<0.001)。
  • 开放简单前列腺切除术再干预风险低于经尿道电切(HR 0.43,95% CI 0.37-0.50,p<0.001)。
  • 激光剜除与经尿道电切再干预风险无显著差异(HR 0.84,95% CI 0.66-1.08,p=0.2)。
  • 针对下尿路症状复发的再干预,光选择性汽化风险更高(HR 1.52,95% CI 1.35-1.72,p<0.001),开放简单前列腺切除术风险更低(HR 0.38,95% CI 0.31-0.46,p<0.001)。

临床怎么用

  • 选择光选择性汽化时应告知患者5年再干预风险高于经尿道电切。
  • 开放简单前列腺切除术在长期再干预风险方面仍具优势,可用于适合开放手术的患者。
  • 激光剜除与经尿道电切的5年再干预风险相当,可作为等效选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: No large-scale comparison of the 4 most established surgical approaches for lower urinary tract symptoms due to benign prostate obstruction in terms of long-term efficacy is available. We compared photoselective vaporization, laser enucleation and open simple prostatectomy to transurethral resection with regard to 5-year surgical reintervention rates. MATERIALS AND METHODS: A total of 43,041 male patients with lower urinary tract symptoms who underwent transurethral resection (34,526), photoselective vaporization (3,050), laser enucleation (1,814) or open simple prostatectomy (3,651) between 2011 and 2013 were identified in pseudonymized claims and core data of the German local health care funds and followed for 5 years. Surgical reinterventions for lower urinary tract symptoms, urethral stricture or bladder neck contracture were evaluated. Surgical approach was related to reintervention risk using the Kaplan-Meier method and Cox proportional hazards models. RESULTS: A total of 5,050 first reinterventions were performed within 5 years of primary surgery (Kaplan-Meier survival without reintervention: 87.5%, 95% CI 87.2%-87.8%). Photoselective vaporization carried an increased hazard of reintervention (HR 1.31, 95% CI 1.17-1.46, p <0.001) relative to transurethral resection, open simple prostatectomy carried a lower hazard (HR 0.43, 95% CI 0.37-0.50, p <0.001) and laser enucleation of the prostate did not differ significantly (HR 0.84, 95% CI 0.66-1.08, p=0.2). This pattern was more pronounced regarding reintervention for lower urinary tract symptom recurrence (photoselective vaporization: HR 1.52, 95% CI 1.35-1.72, p <0.001; laser enucleation of the prostate: HR 0.84, 95% CI 0.63-1.14, p=0.3; open simply prostatectomy: HR 0.38, 95% CI 0.31-0.46, p <0.001 relative to transurethral resection). CONCLUSIONS: Five-year reintervention rates of transurethral resection and laser enucleation did not differ significantly, while photoselective vaporization had a substantially higher rate. Open simple prostatectomy remains superior to transurethral resection with respect to long-term efficacy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Gilfrich C, May M, Fahlenbrach C, et al. Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup. J Urol. 2020. PMID: 33103943. doi:10.1097/JU.0000000000001463

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。